What Is Quality by Design in Pharmaceutical Development?UntitledDesign Quality in from Day One
The Quality by Design Training in the UK teaches you to design quality into pharmaceutical and biopharmaceutical products from the very start, rather than testing for it at the end. Quality by Design (QbD) is a systematic, science-based approach mandated by the ICH Q8(R2), Q9, Q10 and Q11 guidelines and expected by regulators including the MHRA, EMA and FDA in modern development and manufacturing submissions. Over one intensive day you learn to apply the full QbD toolkit: the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment with Ishikawa diagrams and FMEA, Design of Experiments (DoE), the design space, Process Analytical Technology (PAT) and the control strategy. Hands-on exercises use realistic development scenarios, so the methods transfer straight to your projects. The course suits formulation, process development, analytical, quality assurance and CMC regulatory professionals across the UK's pharma, biotech, API and CDMO sectors. Build the process understanding employers now expect and start applying QbD with Invensis Learning.










